Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the ...

An mRNA-based flu vaccine has the potential advantage to more precisely match circulating strains, support rapid response in a future influenza pandemic, and pave the way for COVID-19 combination ...

(The Hill) – Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial. In a Phase 3 study, the company’s mRNA-1010 flu vaccine’s efficacy was nearly ...

Moderna is preparing to test Health Secretary Robert F. Kennedy Jr.'s tougher vaccine policies with a combination flu-COVID ...

The Trump administration’s vaccine advisers took up an old flu-shot debate: whether it’s time to wipe out the last small fraction of those vaccines that contain a controversial preservative ...

The trial readout comes at a time of turbulence in the vaccine sector after RFK Jr replaced every member of the ACIP panel.

The ingredient isn’t used in single-dose flu shots, the type of syringe used for about 95% of U.S. flu shots last season. Status: Kennedy must sign off on the recommendations.

Zoetis received conditional USDA approval for an avian flu vaccine. Major poultry and dairy organizations back vaccine use to control the virus. The Trump administration is rolling out a new ...